FDA’s AER Language Guidance Leaves Room For Interpretation – Consultants
This article was originally published in The Tan Sheet
Executive Summary
As dietary supplement firms revise their product labels to reflect FDA's adverse event reporting draft guidance, some industry experts say acceptable changes are not as onerous as many have feared